Park Ha Biological Technology Co., Ltd.
corporate_fare Company Profile
Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors BYAH SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Park Ha Biological Reports $918K Net Loss, Cash Plummets to $628K; Massive Dilution Authorized
- Park Ha Bio shareholders greenlight a 100x jump in authorized shares, a reverse split as steep as 5,000:1, and super-voting Class B rights
- Park Ha Biological Secures Amazon North America Store Approval, Advancing Global Expansion
- Shareholders to Vote on 100x Authorized Share Increase, Reverse Split Authority, and Enhanced Insider Voting Power
- Park Ha Biological Files PCPC Membership Application for North American Market Entry
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for BYAH, detected from its recent SEC filings · based on capital-structure filings through 2026-06-15.
Offering Finalized · Significant Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
BYAH files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.